A B S T R A C T The fixation of the first component of complement (C'la) by human antibodies and human cells has been studied by the use of the C'la fixation and transfer test (C'la FT test) of Borsos and Rapp.
A B S T R A C T The fixation of the first component of complement (C'la) by human antibodies and human cells has been studied by the use of the C'la fixation and transfer test (C'la FT test) of Borsos and Rapp. Cold agglutinin antibodies appear to require no more than one antibody molecule to fix one molecule of C'1a.
Most warm agglutinin antibodies are IgG in immunoglobulin type and require at least two molecules of antibody to fix a molecule of C'la. Donath-Landsteiner antibody has the same requirements for C'la fixation. A single example of a warm agglutinin antibody which appears to require one molecule of antibody for the fixation of C'la was found.
Antibodies of the Rh system do not fix significant amounts of C'la in the absence of anti-antibody when antiserum of a single Rh specificity was used. However, when three antisera at different specificity are present, C'la may be fixed. Under these conditions cells from a patient with paroxysmal nocturnal hemoglobinuria may be lysed when fresh serum is added to provide the other components of complement. The presence of IgG antibodies could be detected by the use of anti-IgGHu antiserum and a one-toone relationship between the concentration of antiserum in the reaction and the amount of C'la fixed could be established.
The effect of temperature, ionic strength, papainization of the red cells, and repeated washing of the red cell-antibody aggregates on the amount of C'la fixed was investigated. Conditions of maxi-
INTRODUCTION
The fixation by antibody of complement components to red cells of patients with immune hemolytic anemia is, in certain circumstances, an important event leading to the destruction of those cells. In some instances, complement may damage the cell by making small "holes" in the cell membrane (1) . When this occurs, intravascular hemolysis results with consequent hemoglobinemia and hemoglobinuria. In other instances, the presence of complement components on the surface of the circulating red cell appears to render the cell abnormal and to lead to the sequestration and destruction of the cell by the reticuloendothelial system (2) . Hence, information about the fixation of complement by human antibodies is important in understanding the events leading to hemolysis in patients with immune hemolytic anemia.
The first step in the fixation of complement by antibody is the fixation of the first component, C'1 (3) . 1 Once this component is attached by 1The following symbols are commonly used in discussing the reactions of complement: E = a red blood
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The Journal of Clinical Investigation Volume 47 1968 antibody, the remainder of the components will interact sequentially if all are available and cation and temperature requirements are met. Borsos and Rapp (4) and Ishizaka, Ishizaka, Borsos, and Rapp (5) have studied the fixation of C'la by a variety of rabbit antibodies and by human isoimmune anti-A antibodies. They have shown that with these antibodies, a single 1gM antibody molecule is sufficient for the fixation of a molecule of C'la whereas two IgG antibody molecules in juxtaposition are required.
In the present investigation we have studied the fixation of C'la by "autoimmune" and isoimmune human antibodies to human red cells, using the C'la fixation and transfer test of Borsos and Rapp (6) . By this test, the number of molecules of C'la fixed by antibody on each red cell may be calculated and the relationship of this to the amount of antibody present may be determined. This technique not only provides a method for determining the way in which C'la is fixed but also provides a quantitative measure of the amount of antibody attached to the red cell.
METHODS

A. Buffers and complement components
Buffer. Veronal-buffered saline (VBS) was made according to the formula given in reference 3. When buffers of reduced ionic strength were required, this buffer was mixed with appropriate amounts of a buffered isotonic sucrose solution made according to the formula given in reference 7. VBS-sucrose buffer refers to a solution of 40% VBS-60% isotonic sucrose (,g =0.065) unless otherwise stated.
EDTA solution. A 0.1 M solution of EDTA (ethylenediaminetetraacetate, disodium salt) pH 7.4 was made according to the formula given in reference 8. Lower cell (usually from sheep unless otherwise indicated), A = antibody to that red cell (usually made in rabbits unless otherwise indicated), and C' =complement taken as a whole. The individual components are denominated by numbers 1-9 and the activated form of the component is indicated by the letter "a" (e.g. C'la = the activated form of the first component of complement). Cellular intermediates in which some but not all of the components of complement are present at the cell surface are denominated by symbols such as EAC' la, 4 . The sequence of reactions of complement components is thought to be as follows: E + A -*EA + C'1 EAC'la + C'4 .-* EAC'la, 4 + C'2 -> EAC'la, 2 EAC'la, 4, 2a + C'3 --EAC'la, 4, 2, 3 + C'5 -> EAC'la, 4, 2, 3,5 . . +C'9*EAC'la, 4, 2, 3, 5, 6, 7, 8, 9 lysis.
concentrations of EDTA were obtained by diluting this isotonic solution with appropriate amounts of VBS.
Alsever's solution was made according to the formula given in reference 3.
Whole blood was obtained weekly from healthy sheep and was stored at 4°C in an equal volume of Alsever's solution.
Complement. Fresh frozen guinea pig serum, obtained from Suburban Serum Laboratories, Silver Springs, Md., was absorbed twice with a 1/10 volume of washed sheep cells, and was stored at -90°C.
C'la. A solution containing a high concentration of C'la and lacking C'2 and C'4 activity was prepared from guinea pig serum by the method of Borsos and Rapp (9) . This solution contained at least 10 molecules of C'la/ ml and was absorbed twice at 370C and twice at 0°C with packed human red cells before use.
C'2. A solution containing a high concentration of C'2 and lacking C'la, C'4, and "C'3" activity was prepared from guinea pig serum by the method of Borsos, Rapp, and Cook (10) . This solution contained at least 5 X 10" molecules of C'2/ml as determined by the method of Borsos and Rapp (11) .
EAC'4 was made according to the method given in reference 3. In later experiments, the revised method of Borsos and Rapp, using EAC'la and C'-EDTA, was used for making EAC'4 (11 tients with warm-reacting antibodies by the method of Rubin (12) . A brief summary of the clinical status of these patients is given on Table I . Isoimmune antibodies of the Rh system were obtained from Ortho Laboratories, Raritan, N. J. or from patients sensitized during the course of pregnancy. These antibodies were stored at -20'C until use and did not appear to lose their ability to react as antibodies over a period of 18 months.
Human complement. Human serum for complement was obtained from blood collected by venipuncture from normal donors and placed immediately into cooled tubes which were centrifuged at once for 4 min at 10,000 rpm in a refrigerated centrifuge. The The anti-IgM"u was absorbed with human fetal serum and the anti-IgA" with serum from a patient with macroglobulinemia whose serum was deficient in IgA.
D. Procedures
Separation of proteins on Sephadex columns was performed according to the method given in reference 13.
Sephadex G-200 was boiled 5 min, allowed to settle several times while the finer granules were removed, and was put on a 100 cm X 1.0 cm column. The effluent was collected in 3.5-4.0 ml fractions and analyzed for protein content by determining the optical density at 278 m/A using a Beckman DU spectrophotometer.
The C'la fixation and transfer test (C'la FT test) of Borsos and Rapp was performed as outlined in reference 6 with minor modifications. The first part of the test involved the fixation of C'la by EHu and antibody, the removal of the excess C'la, and the release of C'la from the cell-antibody aggregates. For cold-reacting antibodies, the following procedure was used. 0.1 ml of a standard suspension of EHu was mixed in a siliconized test tube at 00C with 0.1-0.4 ml of antiserum and allowed to incubate for 60 min in an ice bath. If a low concentration of serum was used, 0.3 ml C'la solution was added at the onset of the incubation. If a high concentration of serum was used, the cells and antiserum were allowed to incubate 1 hr, were washed twice with ice-cold VBS-sucrose, and were incubated for a further 60 min with 0.3 ml of C'la solution. At the end of this incubation, the cells were washed once in ice-cold VBSsucrose, carefully poured over into a second set of siliconized tubes, and washed three times more with 8 ml of cold VBS-sucrose. At the end of the washing, the cells were suspended in 9 ml of VBS, appropriate dilutions were made, and the amount of C'la in solution was determined by the method of Borsos and Rapp (9) .
When warm-reacting antibodies were used, the 0.1 ml of a standard suspension of EHu was mixed with 0.1-0.4 ml of antiserum diluted appropriately and the mixture was incubated for 30 min at 30'C. The cells were washedtwice with 8 ml of VBS-sucrose and 0.1-0.6 ml of antiglobulin antiserum was added if necessary for the experiment; the mixture was then incubated for 30 min at 30'C. and the cells again washed with 8 ml VBSsucrose. 0.3 ml of C'la solution was added and the mixture incubated for 30 min at 300C. The cell-antibody-C'la aggregates were treated as in the test for cold-reacting antibodies.
The second part of the C'la fixation and transfer test is the determination of the C'la content in solution, using sensitized sheep red cells and guinea pig complement components. After appropriate dilution of the C'la-containing solution (to achieve partial lysis of the sheep cells at the end of the experiment), 0.5 ml was mixed with 0.75 X 108 sheep EAC'4 contained in 0.5 ml of VBS. After allowing the reaction to proceed at 30'C for 15 min, 0.5 ml of C'2 solution containing at least 10'°mole-cules of C'2/ml in isotonic sucrose solution was added and allowed to react for 10 minutes. Following this, 5 ml of a 1/50 dilution of guinea pig serum in ice-cold 0.015 M EDTA was added and the cells placed in a 370C water bath for 60 min. The remaining cells were then removed and optical density of the supernatant fluid at a wavelength of 412 m/A was determined in a spectrophotometer (Gilford Instrument Company, Oberlin, Ohio). Controls for these experiments consisted of: (a) a "cell blank" consisting of 0.5 ml of EAC'4+6.0 ml of VBS-sucrose, (b) a C' color blank consisting of 1.5 ml VBS-sucrose + 5.0 ml C'-EDTA, (c) a "complete blank" consisting of 0.5 ml EAC'4, 0.5 ml VBS-sucrose, 0.5 ml C'2, and 5.0 ml C'-EDTA, and (d) "a complete lysis control" consisting of 0.5 ml EAC'4+6.0 ml 0.01
The net optical density of each sample (optical density less the optical density of the cell control and of the complement color control) was divided by the net complete lysis control (the optical density of the complete lysis control less the optical density of the cell control). This fraction was subtracted from 1.0, and the negative natural logarithm of the result was found (z). The value of z for the complete blank was subtracted and corrected value of z was multiplied by the dilution of the original sample. This yields the number of C'la molecules fixed per EHU, assuming 80%o efficiency in transfer and detection of C'la molecules (6) .
In all experiments, controls in which EHu were incubated with C'la in the absence of antibody and (or)
anti-globulin antibody were performed. The number of molecules of C'la fixed per EHu was usually small and this number was subtracted from all experimental values. All values represent the mean of two or more determinations of the C'la content of the solution derived at the end of the first part of the C'la FT test.
RESULTS
Characteristics of the antibodies
The cold-reacting antibodies. To characterize the molecular species of the-antibodies contained in the serum of patients with cold agglutinin hemolytic anemia, 2-ml aliquots of serum were chromatographed on Sephadex G-200 and the effluent was analyzed for protein content and for antibody content as judged by ability to fix C'la to red cells. In each case, the antibody activity was found in the first (excluded) peak of protein which contained macroglobulin proteins. The antibody in antiserum T. Bu. was further characterized by purification by ultracentrifugation as outlined in reference 1. The antibody activity was found to be in the macroglobulin fraction by this method as well.
Serum from patient J. J. containing a DonathLandsteiner antibody was chromatographed on Sephadex G-200; the antibody activity was de-tected using the C'la FT test by reacting 0.2 ml of effluent with E'u, followed by 0.2 ml of anti-WSHU antibody. The antibody activity was found primarily in the second peak which contained IgG protein.
The warm-reacting antibodies. The antibodies in serum from patients with warm-reacting antibody hemolytic disease were characterized in two ways. (a) The immunoglobulin type of the antibodies was determined by affixing the antibody to EHU, reacting the EHu-antibody aggregates with specific anti-IgGHu, anti-IgMHu or anti-IgAHu antisera, and determining the amount of C'la fixed by the EHu-antibody-antiantibody aggregates by the C'la fixation and transfer test; the results are shown in Table II .
(b) Certain of the antisera were passed through Sephadex G-200 columns and the antibody activity of the effluents determined by sensitizing 0.1 ml of standard EHu with 0.2 ml of effluent, reacting the EHu-antibody aggregates with anti-WSHU, and determining the amount of C'la fixed to the cells by this combination. With the exception of antisera from patients M. W. and M. P., the antibody activity was found in the second peak which contains the IgG immunoglobulins.
Immunological specificity of the antibodies Cold-reacting antibodies. Cold agglutinins are usually classified by their reaction with so-called "I" red cells, i.e., red cells from newborn infants and red cells from rare adults said to be lacking the "I" antigen (14) . The ability of the cold agglutinins used in these studies to fix C'la to normal group 0 red cells was compared to their fixation to group 0 cord cells. The results are re- ported in detail elsewhere 3 but are summarized in Table III . For each antibody, the variation in the amount of C'la fixed by red cells from different donors was great in both groups but the mean value was lower in each case for the "I negative" cells, except for antiserum T. B. Warm-reacting antibodies. Certain warm-reac- the Rh system did not fix C'la to these cells under the same experimental conditions. To determine whether C'la fixed at 00C by cold agglutinin antibody remained attached to the cell when warmed to 370C, we prepared three tubes containing 0.1 ml of a standard suspension of EHu-adult 0.1 ml of a 1/50 dilution of antiserum M. G. containing cold agglutinin antibody, and 0.3 ml of C'la solution. The first tube was incubated at 0C for 30 min., the second at 0C for 30 min and then at 370C for 30 min, and the third was incubated at 370C for 60 min. The amount of C'la fixed per EHu was determined at the end of the incubations by the C'la fixation and transfer test. The results are shown on Table V , part B. C'la was fixed by the antibody in the cold but was released during incubation at 370C. Ionic strength. The effect of ionic strength on the reaction of antibody and EHU was tested by reacting red cells and antibody in either VBS (pu = 0.15) or VBS-sucrose (pm = 0.065), washing the antibody-cell aggregates in the respective buffer, and determining the amount of C'la fixed by the C'la FT test. When warm-reacting antibodies were used, anti-IgGHu in VBS or VBS-sucrose was added to the cell-antibody aggregates and the cells were washed twice with the same buffer before the addition of C'la. The results are shown in Table VI ; in each instance, the amount of antibody fixed was increased by the reduction of the ionic strength by isotonic sucrose.
Repeated washing of the antibody-EH" aggregates. The effect of repeated washing of the antibody-red cell aggregates was assessed by mixing 0.1 ml of EHu and 0.1 ml of antiserum or eluate in a series of tubes. These were incubated at 300C for 30 min and the cell-antibody aggregates were washed two, three, four, and six times, respectively. C'la fixation was estimated by the C'la FT test.
The results are shown on Table VII .
Papainization of the EHU before reaction with antibody. To assess the effect of papainization of the red cell on the fixation of antibody, we performed parallel C'la fixation and transfer tests using either unpapainized cells or papainized cells and several human antibodies. The results are shown on Table VIII. The fixation of C'la in the presence and in the absence of antibody to human immunoglobulins. The effect of the addition of heterologous antibodies to the human immunoglobulins on the amount of C'la fixed by various human antibodies to human red cells was determined by C'la fixation and transfer tests. In each two tubes, 0.1 ml of a standard suspension of EHU was mixed with antiserum or eluate and incubated at either 0C or 300C. The cell-antibody aggregates were washed and 0.1 or 0.2 ml of anti-WS"u was added to one of the cell pellets. After incubation for 30 min the cell-antibody-antiantibody aggregates were washed and C'la was added to both tubes. The amount of C'la fixed was determined by the C'la fixation and transfer test. The results are shown in Table IX .
The four groups of antibodies differ in their fixation of C'la in the absence of anti-globulin antiserum. The cold agglutinin antibodies fix large amounts of C'la even at high dilutions of antiserum and lacking the E (rh") antigen. The relative 2 _ /;#' antibody concentration is plotted on the abscissa, the number of molecules of C'la fixed in the presence of anti-globulin antiserum is plotted cc dd EE on the ordinate; (b) The same as a, using the anti-e (anti-hr") antiserum.
Relative Anti-e Antibody Concentration 27 but only somewhat more is fixed in the presence of anti-antibody (cf . Tables II, III, and IX Antibodies of the Rh system fix insignificant amounts of C'la in the absence of anti-globulinlu. In the presence of anti-antibody, C'la is fixed and the amount varies, depending upon the antibody used and the antigenic composition of the cell with which it is reacted (see Table IV ). In the case of the antibodies anti-E and anti-e, about 1/2-2/3 as much C'la is fixed at maximal antibody concentration by cells homozygous for the specific antigen as by cell heterozygous for that antigen (see Fig.  1 ). However, no such simple relationship is apparent for other antibodies of the Rh system.
The effect of the presence of more than one specific antibody of the Rh system on the red cell at a time on the ability to fix C'la was tested. Red cells were incubated successively with one, two, or three antibodies of the Rh system and the amount of C'la fixed in the presence and absence of anti-antibody was measured. Little or no C'la was fixed by single antibodies or combination of 2 antibodies whereas a large amount of C'la was fixed when all three antibodies are present on the red cell simultaneously. (See Table X When cells from a patient with paroxysmal nocturnal hemoglobinuria were used in such experiments, the ability of such cells to be lysed by C' was tested by adding fresh human serum to the cells after sensitization with 1, 2, or 3 Rh antibodies with and without anti-antibody. The relationship between the amount of antibody present and the amount of G'la fixed in the absence of anti-antibody. Cold agglutinins. C'la FT tests were performed in which the amount of antibody reacting with Ezu was reduced by twofold serial dilution. In the range of limited antibody concentration, the number of molecules of C'la fixed is directly proportional to the amount of cold agglutinin-containing antiserum in the reaction mixture (Fig. 2) . If the logarithm of the relative antibody concentration is plotted against the logarithm of the number of molecules of C'la fixed, a straight line results, the slope of which is about 1.0 for all cold agglutinin-containing antisera tested (see Fig. 3 , Table  II ). This indicates that no more than one antibody molecule is required for the fixation of a C'la molecule. 4 The number of C'la molecules fixed by cold agglutinin antibody is therefore a direct measure of the amount of antibody present on the cell.
Warm agglutinin and Donath-Landsteiner antibodies. When the amount of warm agglutinin or Donath-Landsteiner antibody reacting with EHU is reduced serially, the amount of Cla fixed is not directly related to the relative concentration of the antibody (Fig. 4) . The logarithmic plot of the relative concentration of antibody against the number of molecules of C'la fixed per cell is a straight line, the slope of which is 1.7-2.1 (see Fig. 5 , Table II). This indicates that more than one antibody molecule is required for the fixation of a molecule of C'la. 4 The importance of the slope of the logarithmic plot of relative antibody concentration against the number of molecules of C'la-fixed EHU is derived from the following considerations: The relationship between the concentration of reactant and product is given by the equation
where n = the number of molecules of a reactant which, reacting together, produce the product and K is a proportionality constant. If the logarithm of both sides of the proportionality are taken, log [product] = nlog [reactant] + log K which is the formula of a straight line of slope n. Hence, plotting the logarithm of the reactant concentration against the logarithm of the product concentration yields a straight line of slope n. The numerical value of it gives the mean number of reactant molecules yielding a molecule of the product, i.e., the number of antibody molecules required to fix a molecule of C'la. The dose response curve of antibody M. P. was consistently different than that of the other warm agglutinin antibodies when this antiserum was reacted with EHu in the absence of anti-antibody. In of which was about 1. At high concentrations of antiserum, the slope approached 2.
The relationship between the amount of antibody present and the amount of C'la fixed in the presence of anti-antibody. Warm agglutinin antisera and eluates were diluted in twofold falling dilutions and the amount of C'la fixed by 0.1 ml of a standard suspension of EHu and equal volume of graded dilutions of warm agglutinin antisera or eluates in the presence of a constant amount of anti-human globulin was determined by the C'la fixation and transfer tests. The amount of C'la fixed was proportional to the amount of autoimmune or isoimmune antibody present (in the range of limited antibody). The plot of the logarithm of the relative concentration of autoimmune or isoimmune antibody against the logarithm of the number of molecules of C'la fixed yields a straight line, the slope of which is about 1 (Table II) . The effect of variation in the amount of anti-antibody on the amount of C'la fixed and the slope of the dose-response curve is discussed elsewhere.5
The absorption of globulin in normal serum to normal EHU Globulins present in normal serum appear to be adsorbed to normal red cells in a manner analogous in some respects to the adsorption of antibody. This adsorption is demonstrable in the reaction of red cells and serum from the donor of the cells or from different normal donors. The adsorption of this material is increased by reduction of ionic strength of the reaction mixture and by papainization of the red cells prior to reaction, and is reduced by repeated washing of the cell-serum aggregates. The material reacts with antiIgGHU and to a lesser extent with anti-IgMHu and anti-IgAHu. About 80-100 molecules of C'la are fixed per EHU by 0.2 ml of normal serum in the presence of anti'WSHu antiserum, whereas much less C'la fixation occurs in the absence of antiantibody. The amount of material on the cells detected by anti-WSHu antiserum is directly proportional to the amount of normal human serum present.
DISCUSSION
The fixation of complement by antibodies from patients with autoimmune hemolytic anemia is in part determined by the immunoglobulin type of the antibody. Borsos and Rapp (4) and Ishizaka et al. (5) have shown that only one molecule of IgM antibody appears to be necessary for the fixation of a molecule of C'la whereas at least two molecules of IgG antibody in a "doublet" are required. In the present studies, the cold agglutinin antibodies were found to be IgM in immunoglobulin type, as has been previously described (18, 19) ; these antibodies were found to require no more than one molecule of antibody to fix a molecule of C'la. The Donath-Landsteiner antibody and most of the warm agglutinin antibodies appeared to be IgG in type and to require at least two molecules of antibody to fix a molecule of C'1.
In a previous publication, we have proposed an hypothesis to explain this difference in molecular requirement for C'la fixation deduced from known properties of the structure of IgG and IgM molecules and the study of inactivation of the hemolytic activity of IgG and IgM rabbit anti-Forssman antibodies by ionizing radiation (20) . The IgM molecule consists of at least five subunits, each about the size of an IgG molecule (21) . When IgG antibodies were irradiated, only one radiosensitive target was found per molecule whereas a mean of 3.2 targets was found in IgM antibodies. Using this data, we have suggested that in the IgM molecule, two adjacent subunits are able to act together to fix C'la in the manner of a doublet of IgG molecules.
This difference among different antibodies in the requirements for C' binding is important in determining differences in the manifestations of the hemolytic disease. The antibodies in cold agglutinin disease probably have only a transitory attachment to the red cell as the blood passes to the cooler skin and extremities during circulation. Therefore, the alteration on the surface leading to destruction is not due primarily to antibody but to the complement components fixed to the surface, some of which are detected in the "non-y" Coombs test or as /.ic and 81E. The requirement of only one molecule of antibody to initiate a complement sequence means that such sequences can be initiated efficiently during the passage through the cooled extremity. The present data and the data of Boyer (22) suggest that as the cold reacting antibody dissociate, C'la leaves the cell as well. However, the human C' system is probably analogous to the classic guinea pig C' system, and in that system, once the sequence has proceeded through the addition of C'4 to the cell surface and the activation of C'2 at the site of reaction, the remainder of the reactions can proceed in the absence of C'1 (3) .
Complement rarely causes direct intravascular lysis of the cell but brings about sequestration of the cell in the reticuloendothelial system. The work of Mollison (2) suggests that cells coated with C' components are removed from the circulation by all organs of the reticuloendothelial system, including both liver and spleen, and that the number of cells removed by the liver is greater due to its greater content of reticuloendothelial elements. Hence, splenectomy would be expected to be of little value in treating cold agglutinin disease and seldom is (23) .
On the other hand, the antibodies in warm agglutinin disease are attached very efficiently at body temperature whereas complement fixation, because of the requirement for spatially aligned antibody doublets, is very much less efficient. Hence, the major cause of alteration of the red cell surface leading to destruction of the cell is probably due to the presence of antibody. Cells coated with IgG antibody are preferentially sequestered in the spleen (3), probably by attachment to macrophages there (24) . Hence, splenectomy would be expected to be of value in treatment of this disease, and often is (23) .
The Donath-Landsteiner antibody is anomalous. Although it is cold-reacting and apparently IgG in immunoglobulin type and hence requires doublet formation for C'la fixation, it is a potent hemolytic antibody in vivo in causing hemolysis by the direct lytic action of C'. Certainly part of this potency is due to the very large amount of antibody usually present in the serum but other factors undoubtedly play a role. In other studies, we have compared th amount of lysis of normal or PNH red cells induced by limited concentration of complement in the presence of Donath-Landsteiner antibody, "Anti-I," anti-P, or anti-shigella antibody and adsorbed shigella antigen (24) . In this test ("the complement-lysis sensitivity test") only the Donath-Landsteiner antibody induced an increased sensitivity of normal cells to lysis by C', suggesting that this antibody was able to use small amounts of C' more efficiently in bringing about the lysis of the normal cell than the other antibodies tested. The reasons for this difference are currently under investigation. Antiserum M. P. exhibited several peculiar properties. The antibody appeared to be warmreacting but, unlike most warm-reacting antibodies, considerable amounts of C'la were fixed in the absence of anti-antibody. The logarithmic dose response curve showed a slope of 1 at low concentrations of antibody but approached 2 at higher concentrations. Reactions with the antisera specific for immunoglobulin types showed IgG antibodies to be present. However, on Sephadex gel filtration, antibody activity was found in both the excluded peak and in the peak containing 7S proteins. Those antibodies in the excluded peak readily fix C'la without anti-antibody and are probably responsible for the slope of 1 on the logarithmic dose-response curve at low concentrations of antiserum, whereas those in the 7S peak do not fix C'la readily except at high concentrations of antiserum where they are probably responsible for the slope of 2. Studies are in progress to determine the nature of the antibody in the excluded peak.
Immunoglobulin type is not the only factor determining the efficiency of fixation of C'la. The IgG isoimmune (or autoimmune) antibodies of the Rh system do not appear to fix C'la even when present in maximal amounts on the cell. This is not due to the lack of a C'-fixing site on the antibody molecule since in combinations of several Rh antibodies, C'la is fixed. The inability of antibodies of a single Rh specificity to fix C'la may be due to sparse distribution of antigen sites or to peculiar alignment of the antigen sites. Since the Rh antibodies used here are IgG in immunoglobulin type, two molecules in juxtaposition are needed to fix a molecule of C'la. If the antigen sites of a given specificity were situated at a distance greater than the critical "juxtaposition" distance, C'la could not be fixed. If antigen sites of other specificity were near enough, then the simultaneous presence of antibody molecules of different specificities could lead to the fixation of C'la. These possibilities are being investigated.
Since the cold agglutinin antibodies require only one molecule of antibody for the fixation of C'la, the C'la FT test provides a direct relative measure of antibody concentration on the cell surface. Whether it provides an absolute measure of antibody concentration is less certain. If more than one C'la molecule were fixed per antibody molecule, then the C'la FT test would overestimate the number of antibody molecules. However, the findings of Borsos and Rapp with IgM antiForssman antibody suggest that only one molecule of C'la is fixed per molecule of antibody (25) . On the other hand, the number of antibody molecules on the cell would be underestimated if all antibody molecules were not capable of fixing C'la either because of "steric hindrance" or structural differences among molecules. Preliminary reports by Hoyer, Borsos, Rapp, and Vannier suggest that such heterogeneity may be present in some IgMI antibody preparations (26) but is probably not present in others (25) .
The relationship between the number of antibody molecules on the cell and the number in solution will depend in large part upon the dissociability of the antibody-antigen complex. Since the cold agglutinin antibodies tend to be easily dissociated (some, such as in antiserum M. G. (27) , much more than others) the C'la FT as performed in these studies will tend to underestimate the number of antibody molecules in solution.
The dissociation of cold agglutinin antibodies may be increased or decreased by several alterations in the conditions of the test. Probably the most important factor increasing the association of antibody and erythrocyte is decreased temperature. Because of this, all procedures designed to estimate the maximal fixation of cold-reactive antibody are performed at the lowest practical temperature.
In previous studies (27) we have shown that the fixation of C'la by erythrocyte-antibody complexes enhances the fixation of the antibody to the red cell. Thus, with highly dissociable antibodies (antiserum M. G.) very much less antibody is fixed if C'la is absent during the reaction of cells and antiserum than if it is present. The amount of antibody fixing to red cells is also increased by the prior treatment of the red cells by papain; this is probably due to an alteration in the equilibrium constant of the reaction between antigen and antibody rather than an "uncovering" of antigen sites (28) . Finally the association of antibody and antigen can be increased by reduction of the ionic strength of the reaction mixtures.
Using these facts, the conditions under which C'la is fixed can be designed so that the least amount of dissociation of antibody occurs. At any event, the amount of the underestimation due to dissociation will be the same fraction of the total antibody concentration in solution on each determination, provided the conditions of the test are the same. Hence, the C'la FT test provides a direct estimate of the number of cold agglutinin antibody molecules which are capable of fixing C'la at the red cell surface and a relative estimate of the number of molecules of antibody in solution.
The problems in quantitating the amount of IgG warm agglutinin on the cell surface or in solution Fixation of C'la by Human Antibodies are different from those encountered with coldreacting IgM antibodies. These antibodies are generally less dissociable than the cold agglutinin antibodies but require a "doublet" of molecules for the fixation of C'la. Many single antibody molecules will be undetected by the C'la FT test when anti-antibody is not present. However, if heterologous antibodies directed against the primary antibody are added, C'la is fixed. By proper adjustment of the amount of anti-antibody, a direct proportionality between the amount of antibody in the reaction mixture and the amount of C'la fixed can be established. The constraints upon this method are discussed elsewhere. 5 As with the cold agglutinin antibodies, the method probably underestimates the number of antibody molecules in a solution. This underestimation due to dissociability of the antigen-antibody complex is probably less than with cold reactive antibodies since these antibodies are, in general, less dissociable. Papainization of the red cells and decrease in the ionic strength of the reaction mixture will increase the amount of these antibodies attached to the cells. Again, the proportion of antibody molecules either not attached to the red cell or washed from it during the testing procedure will be constant regardless of antibody concentration.
The finding that the incubation of human red cells with autologous serum results in the attachment of material which can be detected by its reaction with antiserum against the proteins of human serum is not particularly surprising. Gamma globulins are loosely attached to the membrane surface of human red cells and are very difficult to wash away (29) . Either these proteins do not act as antibodies or their concentration is insufficient for the body to declare the cell abnormal since there is no evidence that the process of random destruction (destruction without regard to cell age) seen with antibody-coated cells occurs under normal circumstances (30) . The finding that undiluted autologous serum and rabbit anti-whole human serum antiserum can bring about the fixation of a small amount of C'la indicates that results of serum assays yielding low titers of C'la fixation and transfer must be interpreted with caution with regard to content of specific antibody.
If these constraints upon the estimation of antibody number on the cell and in the solution are taken into consideration, the C'la fixation and transfer test provides a quantitative measure of immunologic reactions occurring on human red cells. Its use in the quantitation of the severity of immune hemolytic disease and in the response of the disease to therapy is the subject of further study.
